Air quality in cities linked to inflammatory risk in diabetes

Exposure to traffic-related air pollutants is associated with a rapid increase in systemic inflammation in patients with diabetes, report Indian researchers.

The team found that among patients attending a diabetes clinic in the city of Pune in India, high concentrations of serum C-reactive protein (CRP) were associated with increased ambient levels of sulfur dioxide (SO2) and nitrogen oxide (NO).

The study was based on data on CRP levels that the researchers had previously collected for diabetic patients as part of the Wellcome Trust Genetic Study, and the patients' exposure to different ambient air pollutants were assessed using data from the National Air Quality Monitoring Program that has been in place since 2004.

As reported in Diabetes Care, 57% percent of 1392 patients had CRP concentrations in the high coronary risk zone (>3 mg/L) and 19% had abnormally raised CRP levels (>10 mg/L).

Each standard deviation increment in city-wide SO2 on the day of blood sample collection was associated with a significant 9.34% increase in CRP concentration and in the 7 days before a clinic visit, with 8.67% to 12.42% increases.

For NO, CRP increased by 7.8% to 11.6% up to 7 days before the visit and by an average of 12.8% 7 days before attending, report Chittaranjan Yajnik, from the King Edward Memorial Hospital Research Center in Pune, and colleagues.

The most significant associations between SO2 and CRP levels were observed among patients with a diabetes duration of less than 7 years and in patients who were not treated with statin or thiazolidinedione therapy.

"Higher inflammatory response in newly diagnosed diabetic patients could be attributed to their younger age and therefore possibly more exposure to outdoor air pollution, and because many were not yet started on medication that lowers inflammation," says the team.

Given existing evidence that CRP levels are associated with the development and complications of the metabolic syndrome, the findings may have implications for the risk for cardiovascular disease in city-dwelling Indian diabetic patients.

In addition, the results "should promote studies on the effect of air pollution on the risk of noncommunicable disease in India," writes the team.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). Air quality in cities linked to inflammatory risk in diabetes. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20121130/Air-quality-in-cities-linked-to-inflammatory-risk-in-diabetes.aspx.

  • MLA

    Robertson, Sally. "Air quality in cities linked to inflammatory risk in diabetes". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20121130/Air-quality-in-cities-linked-to-inflammatory-risk-in-diabetes.aspx>.

  • Chicago

    Robertson, Sally. "Air quality in cities linked to inflammatory risk in diabetes". News-Medical. https://www.news-medical.net/news/20121130/Air-quality-in-cities-linked-to-inflammatory-risk-in-diabetes.aspx. (accessed November 23, 2024).

  • Harvard

    Robertson, Sally. 2018. Air quality in cities linked to inflammatory risk in diabetes. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20121130/Air-quality-in-cities-linked-to-inflammatory-risk-in-diabetes.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SGLT2 inhibitor canagliflozin shown to improve kidney oxygenation in diabetes patients